198 related articles for article (PubMed ID: 35395622)
1. Generation of the integration-free induced pluripotent stem cell line (FHUSTCi001-A) from a patient with glomerulopathy with fibronectin deposits harboring FN1 mutation.
Yu X; Wang H; Xiao F; Jiang S; Li K; Chen Q; Wang G; Kong F; Zhao S
Stem Cell Res; 2022 May; 61():102751. PubMed ID: 35395622
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2(C.5888-1G > C) mutation in the FN1 gene.
She L; Li X; Bai M
Stem Cell Res; 2023 Oct; 72():103203. PubMed ID: 37801747
[TBL] [Abstract][Full Text] [Related]
3. A child with genetic FN1 mutation in the absence of classic glomerulopathy with fibronectin deposits(GFND) findings on biopsy.
Yang XQ; Shen T
BMC Nephrol; 2022 Jul; 23(1):250. PubMed ID: 35836154
[TBL] [Abstract][Full Text] [Related]
4. Mutations in FN1 cause glomerulopathy with fibronectin deposits.
Castelletti F; Donadelli R; Banterla F; Hildebrandt F; Zipfel PF; Bresin E; Otto E; Skerka C; Renieri A; Todeschini M; Caprioli J; Caruso RM; Artuso R; Remuzzi G; Noris M
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2538-43. PubMed ID: 18268355
[TBL] [Abstract][Full Text] [Related]
5. Identification of mutations in FN1 leading to glomerulopathy with fibronectin deposits.
Ohtsubo H; Okada T; Nozu K; Takaoka Y; Shono A; Asanuma K; Zhang L; Nakanishi K; Taniguchi-Ikeda M; Kaito H; Iijima K; Nakamura S
Pediatr Nephrol; 2016 Sep; 31(9):1459-67. PubMed ID: 27056061
[TBL] [Abstract][Full Text] [Related]
6. Generation of an integration-free induced pluripotent stem cell line, FJMUUHi002-A, from a Rett syndrome patient with a heterozygous mutation p. R133C in MeCP2.
Guo Y; Li J; Xie W; Huang H; Li JJ; Lin W; Lu YQ
Stem Cell Res; 2024 Feb; 74():103268. PubMed ID: 38100910
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation.
Wang T; Li J; Xiao Y; Fu B; Wang P; Bai X; Cai G; Chen X; Li Q
Stem Cell Res; 2020 Dec; 49():102039. PubMed ID: 33068887
[TBL] [Abstract][Full Text] [Related]
8. Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).
Goldman BI; Panner BJ; Welle SL; Gross MD; Gray DA
CEN Case Rep; 2021 Nov; 10(4):510-514. PubMed ID: 33837952
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene.
Wang Y; Lv Y; Yang X; Li Y; Li Z; Gao Z; Gai Z; Liu Y
Stem Cell Res; 2022 Oct; 64():102922. PubMed ID: 36183676
[TBL] [Abstract][Full Text] [Related]
10. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
[TBL] [Abstract][Full Text] [Related]
11. A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family.
Dos Reis Monteiro MLG; Custódio FB; de Menezes Neves PDM; Ferreira FM; Watanabe EH; Lerário AM; de Araújo LS; Balbo BEP; Pinto VCD; Barbosa LMG; de Paiva Marques V; Machado JR; Reis MA; Onuchic LF
BMC Nephrol; 2019 Aug; 20(1):322. PubMed ID: 31419955
[TBL] [Abstract][Full Text] [Related]
12. An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene.
Zhu K; Zhao J; Qin F; Chen X; Xu H; Li X; Tao H
Stem Cell Res; 2023 Sep; 71():103182. PubMed ID: 37586167
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
[TBL] [Abstract][Full Text] [Related]
14. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of an induced pluripotent stem cell (iPSC) line SDQLCHi063-A from peripheral blood mononuclear cells of a patient with Maturity-onset diabetes of the young type 2 carrying GCK exon 1 deletion.
Gao M; Li X; Lv Y; Yang X; Liu Y; Gai Z
Stem Cell Res; 2024 Jun; 77():103389. PubMed ID: 38507882
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human iPSC line (SUTCMi001-A) derived from a healthy donor.
Min L; Yin Y; Zhao Q; Wang S
Stem Cell Res; 2022 Aug; 63():102849. PubMed ID: 35843020
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of a human induced pluripotent stem cell line (XWHNi001-A) derived from an Alzheimer's disease patient with mutation in the APP gene.
Wei C; Lu X; Zou Q; Gong S; Chen Y; Lyu J; Jia J
Stem Cell Res; 2022 Apr; 60():102690. PubMed ID: 35149456
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of a human induced pluripotent stem cell line from a Marfan syndrome patient harboring a heterozygous mutation of c.2939G > A in FBN1 gene.
Qin Z; Sun L; Sun X; Gao X; Su H
Stem Cell Res; 2021 Mar; 51():102163. PubMed ID: 33450697
[TBL] [Abstract][Full Text] [Related]
20. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
